Hutch News

Hutch News

Stories tagged 'Jason Bielas'

Bringing personalized oncology to cancer prediction — and prevention

Unique $2.4M NCI-NIEHS award teams Hutch cancer geneticists, epidemiologists and oncologists to use mutation rate to predict individual cancer risk

Oct. 1, 2018 | By Sabrina Richards / Fred Hutch News Service

Drs. Christopher Li, Jason Bielas and colleagues are teaming up on a $2.4 million project that seeks to better understand the link between personal mutation rate and individual cancer risk.

View story >


Squelching ovarian cancer: the not-so-silent killer

The search continues for new biomarkers, better outcomes and, yes, cures for this deadly disease

Sept. 17, 2018 | By Diane Mapes / Fred Hutch News Service

September is Ovarian Cancer Awareness Month, but Fred Hutch researchers are working year-round to find ways to detect the disease early and shut it down for good. Read on for a handful of ovarian cancer research highlights.

View story >


Dr. Kevin Cheung receives prestigious ‘Era of Hope’ Scholar Award

$4.1 million, four-year award to advance understanding of breast cancer metastasis

Feb. 22, 2018 | By Diane Mapes / Fred Hutch News Service

Fred Hutch’s Dr. Kevin Cheung, a metastatic breast cancer researcher, has received a $4.1M Department of Defense Breast Cancer Research Program “Era of Hope” Scholar Award.

View story >


10 highlights of Fred Hutch science in 2017

A look back at notable discoveries in cancer immunotherapy, HIV prevention and more

Dec. 28, 2017 | by Sabin Russell and Susan Keown / Fred Hutch News Service

It's been a year of breakthroughs at Fred Hutch. Here are 10 of our favorites.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

March 31, 2017

Dr. Philip Greenberg elected to serve on AACR board of directors; five researchers receive awards to explore immunotherapy single-cell RNA sequencing.

View story >


How to be a curestarter

A longtime Fred Hutch booster helps a promising genetic researcher parlay $100K into a $2.2M grant to explore innovative new therapies

Feb. 24, 2017 | By Diane Mapes and Rachel Tompa / Fred Hutch News Service

Funding for novel and unexpected findings isn’t always forthcoming, especially in a climate in which only the top 7 percent or so grants submitted to the National Institutes of Health are given a green light. This is a story of how a longtime Fred Hutch booster helped a promising cancer geneticist parlay $100K into a $2.2M grant.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.